Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2026-01-18 @ 9:01 AM
Study NCT ID:
NCT07264634
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-04
First Post:
2025-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
Sponsor:
Ascendis Pharma A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-24
First Submit QC Date:
None
Study First Post Date:
2025-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED